Nasdaq

Medtronic Announces European Launch of World's First Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes

DUBLIN, April 14, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first ...
Nasdaq

Medtronic InPen™ Real-World Data and Extended Infusion Set* Pivotal Trial Results Demonstrate Strong Clinical Outcomes and Positive User Experience

DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...
Healio

Extended-wear insulin infusion set lasts 7 days for most wearers, with few adverse events

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel extended-wear insulin infusion set was usable ...
FierceBiotech

FDA clears BD insulin infusion set developed with diabetes patient advocacy groups

Becton Dickinson ($BDX) worked with diabetes patient advocate groups to develop its latest insulin infusion set, which is designed for improved insulin flow with ...
Business Wire

Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary ...